Medicines360 Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medicines360's estimated annual revenue is currently $11.9M per year.(i)
  • Medicines360's estimated revenue per employee is $201,000

Employee Data

  • Medicines360 has 59 Employees.(i)
  • Medicines360 grew their employee count by -16% last year.

Medicines360's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
EVP, Policy and Strategic Market AccessReveal Email/Phone
3
VP Marketing CommunicationsReveal Email/Phone
4
VP, Strategic DevelopmentReveal Email/Phone
5
VP Product DevelopmentReveal Email/Phone
6
VP, Finance & AccountingReveal Email/Phone
7
SVP, Quality and Product SafetyReveal Email/Phone
8
Director Marketing and CommunicationsReveal Email/Phone
9
Director Regulatory AffairsReveal Email/Phone
10
Senior Director, Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Medicines360?

Medicines360 is a non-profit pharmaceutical company and social enterprise working toward self-sustainability through commercial sales revenue that develops innovative, affordable, and sustainable medical solutions for women. Profit is a means of achieving our mission, not our motive; we exist to meet the medical needs of all women.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$11.9M

Revenue (est)

-16%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medicines360 News

2022-04-17 - Global Intrauterine Contraceptive Devices (IUCD) Market ...

... (IUCD) Market 2022 Growth Statistics by Key Vendors – Bayer Healthcare AG, Teva Pharmaceutical Industries Ltd, Actavis PLC, Medicines360.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.6M59-3%$71.6M
#2
$7.7M59-47%N/A
#3
$7.4M5913%N/A
#4
$7.7M595%N/A
#5
$7.4M59-5%$68.1M